What is GeneriCo?
GenericO Pharma is a pharmaceutical company dedicated to the production and distribution of generic medications. The company's mission is to enhance health outcomes by providing accessible and high-quality pharmaceutical products to a broad spectrum of clients, including healthcare providers and individual patients. As GenericO Pharma prepares for product launch, it aims to establish a strong presence in the market by focusing on affordability and widespread availability of essential medicines.
How much funding has GeneriCo raised?
GeneriCo has raised a total of $5.3M across 2 funding rounds:
Private Equity
$3.8M
Series A
$1.5M
Private Equity (2015): $3.8M, investors not publicly disclosed
Series A (2015): $1.5M led by Missouri Technology, BioGenerator, and Kinsale Capital Partners, LLC
Key Investors in GeneriCo
Missouri Technology
The Missouri Technology Corporation (MTC) is a public-private partnership focused on fostering entrepreneurship and supporting high-tech companies, particularly in life sciences and technology sectors. MTC provides venture capital, grants, and ecosystem support to emerging businesses in Missouri.
BioGenerator
BioGenerator is an organization based in St. Louis that focuses on creating and growing innovative companies within the life sciences sector through venture investment and comprehensive startup support.
Kinsale Capital Partners, LLC
Kinsale Capital Partners is a merchant bank specializing in equity solutions for middle-market companies, investing its own capital and co-investment funds to support growth and strategic initiatives.
What's next for GeneriCo?
With the recent major strategic investment, GeneriCo is well-positioned to accelerate its product launch and market penetration. This significant capital infusion is expected to fuel expansion initiatives, enhance research and development capabilities, and bolster marketing efforts to reach a wider patient base. The company's focus on generic medications suggests a strategy aimed at capturing market share through competitive pricing and broad accessibility, aligning with the growing demand for cost-effective healthcare solutions.
See full GeneriCo company page
